CYTOKINETICS INC
CYTK
92 insider filings · Latest: Oct 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Oct 13 8:00 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $62.88 | $471.6K | 278,544(D) | View → |
| Oct 12, 2026 | Oct 13 12:19 PM | ROBERT BLUM | Proposed Sale | 22,500 | $62.91 | $1.4M | — | View → |
| Oct 6, 2026 | Oct 6 8:25 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $61.38 | $214.8K | 153,902(D) | View → |
| Sep 28, 2026 | Sep 28 8:54 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $65.46 | $490.9K | 278,544(D) | View → |
| Sep 22, 2026 | Sep 22 10:14 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $68.29 | $239.0K | 153,902(D) | View → |
| Sep 15, 2026 | Sep 15 9:51 PM | Robert I. Blum | Proposed Sale | 97,926 | $72.45 | $7.1M | — | View → |
| Sep 15, 2026 | Sep 15 9:23 PM | Robert E LandryDirector | Sale | 1,000 | $72.13 | $72.1K | 8,184(D) | View → |
| Sep 15, 2026 | Sep 15 9:20 PM | Robert I BlumDirector, President & CEO | Sale | 97,926 | $69.33 | $6.8M | 0(I) | View → |
| Sep 14, 2026 | Sep 15 9:20 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $73.44 | $550.8K | 377,820(D) | View → |
| Sep 11, 2026 | Sep 11 11:12 PM | Robert E LandryDirector | Sale | 1,000 | $74.66 | $74.7K | 9,184(D) | View → |
| Sep 11, 2026 | Sep 11 8:30 PM | ROBERT LANDRY | Proposed Sale | 2,000 | $73.62 | $147.2K | — | View → |
| Sep 8, 2026 | Sep 8 8:38 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $75.46 | $264.1K | 153,902(D) | View → |
| Sep 1, 2026 | Sep 1 8:51 PM | Lynne B ParshallDirector | Sale | 5,000 | $71.48 | $357.4K | 10,784(D) | View → |
| Sep 1, 2026 | Sep 1 8:48 PM | B LYNNE PARSHALL | Proposed Sale | 5,000 | $70.91 | $354.6K | — | View → |
| Aug 31, 2026 | Aug 31 8:57 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 10,000 | $70.24 | $702.4K | 58,555(D) | View → |
| Aug 31, 2026 | Aug 31 8:55 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $70.24 | $526.8K | 377,820(D) | View → |
| Aug 18, 2026 | Aug 18 8:38 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $75.82 | $265.4K | 153,902(D) | View → |
| Aug 10, 2026 | Aug 10 9:11 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $76.76 | $575.7K | 377,820(D) | View → |
| Jul 30, 2026 | Jul 30 8:26 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 14,000 | $79.88 | $1.1M | 58,555(D) | View → |
| Jul 30, 2026 | Jul 30 8:22 PM | ANDREW CALLOS | Proposed Sale | 24,000 | $78.39 | $1.9M | — | View → |
Page 1 of 7
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 9 9:40 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 44,386(D) | View → |
| Jun 1, 2026 | Jun 1 10:51 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 39,000(D) | View → |
| May 27, 2026 | May 27 11:16 PM | Muna BhanjiDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:14 PM | James M DalyDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:13 PM | Robert Arthur HarringtonDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:12 PM | John T HendersonDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:11 PM | Edward M. Kaye MDDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:10 PM | Lynne B ParshallDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:09 PM | Robert E LandryDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:08 PM | Wendell WierengaDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:07 PM | Nancy WysenskiDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 19, 2026 | May 20 8:00 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 47,886(D) | View → |
| May 5, 2026 | May 5 9:35 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 51,386(D) | View → |
| May 5, 2026 | May 5 8:20 PM | Wendell WierengaDirector | Option Exercise | 4,032 | $12.40 | 0(D) | View → |
| May 5, 2026 | May 5 8:15 PM | John T HendersonDirector | Option Exercise | 20,000 | $7.61 | 0(D) | View → |
| May 5, 2026 | May 5 8:11 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 11,333 | $39.13 | 13,070(D) | View → |
| May 1, 2026 | May 4 8:01 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,857 | $37.63 | 0(D) | View → |
| Apr 30, 2026 | Apr 30 8:22 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 54,000(D) | View → |
| Apr 21, 2026 | Apr 21 8:22 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 54,886(D) | View → |
| Apr 7, 2026 | Apr 8 8:18 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 4,500 | $10.60 | 0(D) | View → |